Haihe Biopharma is a China-based, innovation-driven biotechnology company focused on discovering, developing, producing and commercialising novel oncology drugs. The company has raised several large funding rounds, including a ¥1.2 billion Series B and a US$146.6 million financing to accelerate its global development efforts.
Focus Areas
Notable Investments
